CENTOGENE Webinar Header Person in Front of a Screen

Illumina and CENTOGENE

Using NIPT to Screen for the Most Common Fetal Chromosomal Abnormalities

July 24, 2017
3 p.m. CEST

Watch on demand

Using NIPT To Screen for the Most Common Fetal Chromosomal Abnormalities

Illumina VeriSeq™ NIPT Solution*

CENTOGENE has a new addition to its prenatal portfolio: CentoNIPT®, its innovative non-invasive prenatal testing that provides a fast and accurate screening for the most common prenatal chromosomal abnormalities (Trisomy 21, Trisomy 18, Trisomy 13 and sex chromosomes).

CentoNIPT® combines next generation sequencing with integrated measurement of fetal fraction, even when the fetal fraction is less than 4%. Based on the Illumina Verifi Prenatal Test & VeriSeq™ NIPT solution, CentoNIPT® promises the lowest test failure rate among NIPT technologies on market (30 – 50 % lower).

Webinar Content

  • Introduction to NIPT and difference with classic prenatal testing
  • Methodology/technology
  • Pre-test and post-test counseling considerations
  • Report example – CENTOGENE base

Notation: *Sample Preparation and analysis software are CE-IVD marked.

Our Speakers

CENTOGENE Webinar Speaker Kristin Dalton

Kristin Dalton

Genetic Counselor at Illumina

Kristin Dalton, a licensed and certified Genetic Counselor, joined Illumina's […]

CENTOGENE Webinar Speaker Peter Bauer

Prof. Peter Bauer, M.D.

Chief Genomic Officer, CENTOGENE

Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Genomic Officer, where he combines […]

CENTOGENE Webinar CentoTalk Person in front of a Computer

Externe Inhalte von Youtube anzeigen?

Beim Laden dieser Inhalte werden Daten an den Anbieter und ggf. an Dritte übertragen. Weitere Informationen können sie in unseren Datenschutzbestimmungen nachlesen.

Inhalt anzeigen
CENTOGENE Webinars CentoTalk Header Person Infront of a Screen

Watch Our CentoTalks on demand

Our interactive webinars that feature key developments in clinical diagnostics.

All recorded webinars